Heron Therapeutics's total assets for Q2 2026 were $252.26M, an increase of 2.46% from the previous quarter. CH:AXD2 total liabilities were $245.35M for the fiscal quarter, a 3.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.